Apitolisib

TargetMol
Product Code: TAR-T1916
Supplier: TargetMol
CodeSizePrice
TAR-T1916-2mg2mg£101.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1916-5mg5mg£117.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1916-1mL1 mL * 10 mM (in DMSO)£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1916-10mg10mg£141.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1916-25mg25mg£198.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1916-50mg50mg£278.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1916-100mg100mg£410.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Apitolisib, an effective, class I PI3K inhibitor for PI3Kα?IC50=5 nM?, PI3Kβ?IC50=27 nM?, PI3Kδ?IC50=7 nM?, PI3Kγ ?IC50=14 nM?, is used in trials study of solid cancers, breast cancer, prostate cancer, renal cell carcinoma, and endometrial carcinoma, among others.
CAS:
1032754-93-0
Formula:
C23H30N8O3S
Molecular Weight:
498.6
Pathway:
Apoptosis; PI3K/Akt/mTOR signaling
Purity:
0.9952
SMILES:
c12sc(CN3CCN(C(=O)[C@@H](O)C)CC3)c(C)c1nc(c1cnc(N)nc1)nc2N1CCOCC1
Target:
Apoptosis; PI3K; mTOR

References

1. Sutherlin DP, et al. J Med Chem, 2011, 54(21), 7579-7587. 2. Wallin JJ, et al. Mol Cancer Ther, 2011, 10(12), 2426-2436. 3. Makhov PB, et al. 2012. doi: 10.1158/1535-7163. MCT-11-0907.